Has anyone participated in clinical trials involving Brelovitug (BJT-778) or Bulevirtide?

Hello everyone

I would like to learn from people who have previously participated in clinical trials involving Brelovitug (BJT-778), Bulevirtide, or similar treatments for chronic hepatitis D (HDV).

If you have personal experience with any of these treatments, would you be willing to share some information about your experience?

For example:

  • Did your HDV RNA decrease during treatment?
  • How did your ALT and AST levels change?
  • Did you notice any improvement in how you felt physically?
  • What side effects or other difficulties did you experience?
  • Were there any serious or unexpected problems?
  • How long did it take before you noticed changes?
  • What happened after the treatment ended or was stopped?
  • What were the main positive and negative aspects of your experience?

We are especially interested in hearing from people who have actually received these treatments as part of a clinical trial.

Even a short description of your experience would be very helpful. Personal experiences and information are greatly appreciated.

Thank you to everyone who is willing to share…

1 Like